Enzo Biochem (ENZ) Reports Q4 EPS of $0.77
Tweet
Share
E-mailGet Alerts ENZ Hot Sheet
Price: $0.31 --0%
Financial Fact:
Provision for uncollectible accounts receivable: 669K
Today's EPS Names:
OCCI, ALZN, ASPU, More
Financial Fact:
Provision for uncollectible accounts receivable: 669K
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Enzo Biochem (NYSE: ENZ) reported Q4 EPS of $0.77, versus $0.18 reported last year. Revenue for the quarter came in at $26.6 million, versus $25.7 million reported last year.
For earnings history and earnings-related data on Enzo Biochem (ENZ) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Royal Caribbean to acquire 50% stake in Sandals Resorts for $3 billion
- Oppenheimer Starts Viatris (VTRS) at Outperform
- Goldman Sachs Downgrades Bank Mandiri (BMRI:IJ) (PPERF) to Sell, 'Liquidity and capital tightness'
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
